|
Hypertrophy
Citations 391-400 of 489 total displayed.
|
Past content
(since Jan 1999):
|
- Clinical Investigations and Reports
Peroxisome Proliferator–Activated Receptor  Gene Regulates Left Ventricular Growth in Response to Exercise and Hypertension
- Yalda Jamshidi, Hugh E. Montgomery, Hans-Werner Hense, Saul G. Myerson, Ines Pineda Torra, Bart Staels, Michael J. World, Angela Doering, Jeanette Erdmann, Christian Hengstenberg, Steve E. Humphries, Heribert Schunkert, and David M. Flavell
Circulation 2002;105:950-955; published online before print as doi:10.1161/hc0802.104535
[Abstract]
[Full text]
- Images in Cardiovascular Medicine
Magnetic Resonance Contrast Enhancement of Iatrogenic Septal Myocardial Infarction in Hypertrophic Cardiomyopathy
- Burkhard Sievers, James C.C. Moon, and Dudley J. Pennell
Circulation 2002;105:1018, doi:10.1161/hc0802.101576
[Full text]
- Articles
Effects of Cariporide and Losartan on
Hypertrophy, Calcium Transients,
Contractility, and Gene Expression in Congestive Heart
Failure
- Jan P. Loennechen, Ulrik Wisløff, Geir Falck, and
 yvind Ellingsen
Circulation published February 25, 2002, doi:10.1161/hc1102.105258
[Abstract]
- Clinical Investigations and Reports
Relationship Between Treatment-Induced Changes in Left Ventricular Mass and Blood Pressure in Black African Hypertensive Patients: Results of the Baragwanath Trial
- Daniel Skudicky, Pinhas Sareli, Elena Libhaber, Geoffrey Candy, Ivo Radevski, Zdravska Valtchanova, Elizabeth Tshele, Lutgarde Thijs, Ji-Guang Wang, and Jan A. Staessen
Circulation 2002;105:830-836; published online before print as doi:10.1161/hc0702.104162
[Abstract]
[Full text]
- Correspondence
Heart Failure With a Normal Ejection Fraction • Response
- Yoram Agmon, Jonathan Lessick, Shimon A. Reisner, Michael R. Zile, William H. Gaasch, John D. Carroll, Marc D. Feldman, Gerard P. Aurigemma, Gary L. Schaer, Philip R. Liebson, and Jalal K. Ghali
Circulation 2002;105:e48
[Full text]
- Brief Rapid Communications
Calcineurin Inhibition Attenuates Mineralocorticoid-Induced Cardiac Hypertrophy
- Yoshiyu Takeda, Takashi Yoneda, Masashi Demura, Mikiya Usukura, and Hiroshi Mabuchi
Circulation 2002;105:677-679, doi:10.1161/hc0602.104675
[Abstract]
[Full text]
- Articles
Peroxisome Proliferator--Activated
Receptor  Plays a Critical Role in Inhibition of Cardiac
Hypertrophy In Vitro and In Vivo
- Masayuki Asakawa, Hiroyuki Takano, Toshio Nagai, Hiroki Uozumi, Hiroshi Hasegawa, Naoto Kubota, Toshihiro Saito, Yoshiaki Masuda, Takashi Kadowaki, and Issei Komuro
Circulation published February 11, 2002, doi:10.1161/hc1002.105225
[Abstract]
- Articles
Change in Diastolic Left
Ventricular Filling After One Year of Antihypertensive
Treatment. The Losartan Intervention For Endpoint
Reduction in Hypertension (LIFE) Study
- Kristian Wachtell, Jonathan N. Bella, Jens Rokkedal, Vittorio Palmieri, Vasilios Papademetriou, Björn Dahlöf, Tapio Aalto, Eva Gerdts, and Richard B. Devereux
Circulation published February 11, 2002, doi:10.1161/hc0902.104599
[Abstract]
- Articles
Remodeling of Left Ventricular
Hypertrophy in Elite Athletes After Long-Term
Deconditioning
- Antonio Pelliccia, Barry J. Maron, Rosanna De
Luca, Fernando M. Di Paolo, Antonio Spataro, and Franco Culasso
Circulation published February 4, 2002, doi:10.1161/hc0802.104534
[Abstract]
- Clinical Investigations and Reports
Sarcomere Protein Gene Mutations in Hypertrophic Cardiomyopathy of the Elderly
- Hideshi Niimura, Kristen K. Patton, William J. McKenna, Johann Soults, Barry J. Maron, J.G. Seidman, and Christine E. Seidman
Circulation 2002;105:446-451, doi:10.1161/hc0402.102990
[Abstract]
[Full text]
|
|
